2024 ICD-10-CM Diagnosis Code T47.6X5D

Adverse effect of antidiarrheal drugs, subsequent encounter

ICD-10-CM Code:
T47.6X5D
ICD-10 Code for:
Adverse effect of antidiarrheal drugs, subsequent encounter
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Not chronic
Code Navigator:

Code Classification

  • Injury, poisoning and certain other consequences of external causes
    (S00–T88)
    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
      (T36-T50)
      • Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system
        (T47)

T47.6X5D is a billable diagnosis code used to specify a medical diagnosis of adverse effect of antidiarrheal drugs, subsequent encounter. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. The code is exempt from present on admission (POA) reporting for inpatient admissions to general acute care hospitals.

This code describes a circumstance which influences the patient's health status but not a current illness or injury. The code is unacceptable as a principal diagnosis.

T47.6X5D is a subsequent encounter code, includes a 7th character and should be used after the patient has completed active treatment for a condition like adverse effect of antidiarrheal drugs. According to ICD-10-CM Guidelines a "subsequent encounter" occurs when the patient is receiving routine care for the condition during the healing or recovery phase of treatment. Subsequent diagnosis codes are appropriate during the recovery phase, no matter how many times the patient has seen the provider for this condition. If the provider needs to adjust the patient's care plan due to a setback or other complication, the encounter becomes active again.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Adverse reaction to aluminum and/or aluminum compound
  • Adverse reaction to bismuth and/or bismuth compound
  • Adverse reaction to bismuth subnitrate and/or iodoform
  • Adverse reaction to diphenoxylate
  • Adverse reaction to pectin
  • Antidiarrheal drug adverse reaction
  • Charcoal activated adverse reaction
  • Kaolin adverse reaction
  • Loperamide adverse reaction
  • Non-melanin pigmentation due to exogenous substance
  • Pigmentation due to bismuth

Clinical Classification

Clinical Information

  • 1,4-alpha-Glucan Branching Enzyme

    in glycogen or amylopectin synthesis, the enzyme that catalyzes the transfer of a segment of a 1,4-alpha-glucan chain to a primary hydroxy group in a similar glucan chain. ec 2.4.1.18.
  • Amylopectin

    a highly branched glucan in starch.
  • Glycogen Storage Disease Type IV

    an autosomal recessive metabolic disorder due to a deficiency in expression of glycogen branching enzyme 1 (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. clinical features are muscle hypotonia and cirrhosis. death from liver disease usually occurs before age 2.
  • Charcoal

    an amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. the activated form of charcoal is used in the treatment of poisoning. (grant & hackh's chemical dictionary, 5th ed)
  • Diphenoxylate

    a meperidine congener used as an antidiarrheal, usually in combination with atropine. at high doses, it acts like morphine. its unesterified metabolite difenoxin has similar properties and is used similarly. it has little or no analgesic activity.
  • Kaolin

    the most common mineral of a group of hydrated aluminum silicates, approximately h2al2si2o8-h2o. it is prepared for pharmaceutical and medicinal purposes by levigating with water to remove sand, etc. (from merck index, 11th ed) the name is derived from kao-ling (chinese: "high ridge"), the original site. (from grant & hackh's chemical dictionary, 5th ed)
  • Partial Thromboplastin Time

    the time required for the appearance of fibrin strands following the mixing of plasma with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). it is a test of the intrinsic pathway (factors viii, ix, xi, and xii) and the common pathway (fibrinogen, prothrombin, factors v and x) of blood coagulation. it is used as a screening test and to monitor heparin therapy.
  • Bacillus coagulans

    a microaerophilic, lactic acid producing species of bacillus that occurs in fermented foods. it also produces anti-infective agents and is used as a probiotic.
  • Lacticaseibacillus casei

    a rod-shaped bacterium isolated from milk and cheese, dairy products and dairy environments, sour dough, cow dung, silage, and human mouth, human intestinal contents and stools, and the human vagina. l. casei is catalase positive.
  • Lacticaseibacillus paracasei

    a species of lacticaseibacillus that occurs in the gut microbiota of healthy humans as well as fermented dairy products and fermented vegetables. it is used as a probiotic.
  • Lacticaseibacillus rhamnosus

    a species of gram-positive, rod-shaped bacteria used in probiotics.
  • Lactobacillus

    a genus of gram-positive, microaerophilic, rod-shaped bacteria occurring widely in nature. its species are also part of the many normal flora of the mouth, intestinal tract, and vagina of many mammals, including humans. lactobacillus species are homofermentative and ferment a broad spectrum of carbohydrates often host-adapted but do not ferment pentoses. most members were previously assigned to the lactobacillus delbrueckii group. pathogenicity from this genus is rare.
  • Lactobacillus acidophilus

    a species of gram-positive, rod-shaped bacteria isolated from the intestinal tract of humans and animals, the human mouth, and vagina. this organism produces the fermented product, acidophilus milk.
  • Lactobacillus crispatus

    a species of lactobacillus that occurs in the human gastrointestinal tract and the vagina of healthy women. it produces lactic acid and hydrogen peroxide, and is used as a probiotic. it is also used for the treatment and prevention of bacterial vaginosis.
  • Lactobacillus delbrueckii

    a species of gram-positive, rod-shaped, facultatively anaerobic bacteria. capable of producing lactic acid. it is important in the manufacture of fermented dairy products.
  • Lactobacillus gasseri

    a species of lactobacillus that occurs in the human oral mucosa; gastrointestinal tract; and vagina. it produces bacteriocins, can modulate the immune response, and is used as a probiotic.
  • Lactobacillus helveticus

    a species of gram-positive bacteria isolated from milk and cheese-starter cultures.
  • Lactobacillus johnsonii

    a species of lactobacillus that occurs in the human gastrointestinal tract and vagina. it produces bacteriocins and hydrogen peroxide and is used as a probiotic.
  • Lactobacillus leichmannii

    a species of gram-negative bacteria isolated from milk, cheese, and compressed yeast.
  • Lactobacillus pentosus

    a species of lactobacillus that occurs in fermented foods where its ability to produce lactic acid; anti-infective agents; and bacteriocins make it useful as a food preservation agent. it is also used as a probiotic.
  • Lactobacillus plantarum

    a species of rod-shaped, lactic acid bacteria used in probiotics and silage production.
  • Latilactobacillus sakei

    a species of lactobacillus that occurs in fermented meat and fish. it produces the bacteriocin sakacin p and is used for food preservation and as a probiotic.
  • Levilactobacillus brevis

    a species of gram-positive, rod-shaped lactic acid bacteria that is frequently used as starter culture in silage fermentation, sourdough, and lactic-acid-fermented types of beer and wine.
  • Ligilactobacillus salivarius

    a species of lactobacillus that occurs in the human gastrointestinal tract and oral mucosa. it produces bacteriocins and is used as a probiotic.
  • Limosilactobacillus fermentum

    a species of gram-positive, rod-shaped bacteria associated with dental caries.
  • Limosilactobacillus reuteri

    a species of gram-positive, rod-shaped lactic acid bacteria found naturally in the human intestinal flora and breast milk.
  • Loperamide

    one of the long-acting synthetic antidiarrheals; it is not significantly absorbed from the gut, and has no effect on the adrenergic system or central nervous system, but may antagonize histamine and interfere with acetylcholine release locally.
  • Saccharomyces boulardii

    a species of saccharomyces that is used as a probiotic, such as in the treatment of diarrhea and pseudomembranous enterocolitis associated with clostridium infections.

Coding Guidelines

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of agents primarily affecting the gastrointestinal system (T47). Use the following options for the aplicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Code Edits

The Medicare Code Editor (MCE) detects and reports errors in the coding of claims data. The following ICD-10-CM Code Edits are applicable to this code:

  • Unacceptable principal diagnosis - There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Present on Admission (POA)

T47.6X5D is exempt from POA reporting - The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement. Review other POA exempt codes here.

CMS POA Indicator Options and Definitions

POA IndicatorReason for CodeCMS will pay the CC/MCC DRG?
YDiagnosis was present at time of inpatient admission.YES
NDiagnosis was not present at time of inpatient admission.NO
UDocumentation insufficient to determine if the condition was present at the time of inpatient admission.NO
WClinically undetermined - unable to clinically determine whether the condition was present at the time of inpatient admission.YES
1Unreported/Not used - Exempt from POA reporting. NO

Convert T47.6X5D to ICD-9-CM

  • ICD-9-CM Code: V58.89 - Other specfied aftercare
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Table of Drugs and Chemicals

The parent code T47.6X5 of the current diagnosis code is referenced in the Table of Drugs and Chemicals, this table contains a classification of drugs, industrial solvents, corrosive gases, noxious plants, pesticides, and other toxic agents.

According to ICD-10-CM coding guidelines it is advised to do not code directly from the Table of Drugs and Chemicals, instead always refer back to the Tabular List when doing the initial coding. Each substance in the table is assigned a code according to the poisoning classification and external causes of adverse effects. It is important to use as many codes as necessary to specify all reported drugs, medicinal or chemical substances. If the same diagnosis code describes the causative agent for more than one adverse reaction, poisoning, toxic effect or underdosing, utilize the code only once.

Substance Poisoning
Accidental
(unintentional)
Poisoning
Accidental
(self-harm)
Poisoning
Assault
Poisoning
Undetermined
Adverse
effect
Underdosing
Activated charcoal [See Also: Charcoal, medicinal]T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
AmylopectinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Antidiarrheal drug NECT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Antidiarrheal drug NEC
  »absorbent
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
AttapulgiteT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth saltsT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »aluminate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »anti-infectives
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »formic iodide
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »glycolylarsenate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »nonmedicinal (compounds) NEC
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »subcarbonate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »subsalicylate
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Bismuth salts
  »sulfarsphenamine
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Carbo medicinalisT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
CharcoalT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »activated [See Also: Charcoal, medicinal]
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »fumes (Carbon monoxide)
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »fumes (Carbon monoxide)
    »industrial
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »antidiarrheal
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »poison control
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »specified use other than for diarrhea
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Charcoal
  »medicinal (activated)
    »topical
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
DifenoxinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
DiphenoxylateT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
FetoxilateT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Intestinal motility control drugT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Intestinal motility control drug
  »biological
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
KaolinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Kaolin
  »light
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
LactobacillusT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »acidophilus
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »acidophilus
    »compound
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »bifidus, lyophilized
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »bulgaricus
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lactobacillus
  »sporogenes
T47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Lignin hemicelluloseT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
LomotilT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
LoperamideT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Miyari bacteriaT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
PectinT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6
Saccharomyces boulardiiT47.6X1T47.6X2T47.6X3T47.6X4T47.6X5T47.6X6

Patient Education


Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

What is a drug interaction?

A drug interaction is a change in the way a drug acts in the body when taken with certain other drugs, foods, or supplements or when taken while you have certain medical conditions. Examples include:

  • Two drugs, such as aspirin and blood thinners
  • Drugs and food, such as statins and grapefruit
  • Drugs and supplements, such as gingko and blood thinners
  • Drugs and medical conditions, such as aspirin and peptic ulcers

Interactions could cause a drug to be more or less effective, cause side effects, or change the way one or both drugs work.

What are side effects?

Side effects are unwanted, usually unpleasant, effects caused by medicines. Most are mild, such as a stomachache, dry mouth, or drowsiness, and go away after you stop taking the medicine. Others can be more serious. Sometimes a drug can interact with a disease that you have and cause a side effect. For example, if you have a heart condition, certain decongestants can cause you to have a rapid heartbeat.

What are drug allergies?

Drug allergies are another type of reaction. They can range from mild to life-threatening. Skin reactions, such as hives and rashes, are the most common type. Anaphylaxis, a serious allergic reaction, is less common.

How can I stay safe when taking medicines?

When you start a new prescription or over-the-counter medicine, make sure you understand how to take it correctly. Know which other medicines, foods, and supplements you need to avoid. Always talk to your health care provider or pharmacist if you have questions about your medicines.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.